Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |